COMMUNIQUÉS West-GlobeNewswire

Guerbet annonce que Vectorio®, un dispositif médical innovant pour les procédures cTACE, a reçu le marquage CE
14/09/2017
Vectorio ® sera présenté lors des prochains congrès de radiologie Villepinte (France), le 14 septembre 2017 (18 heures CEST) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour [...]
Guerbet Announces CE Mark for Vectorio®, An Innovative Medical Device for cTACE Procedures
14/09/2017
Vectorio ® will be presented at the upcoming radiology congresses Villepinte (France), September 14, 2017 (6:00 PM CEST) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical [...]
Nestlé acquires majority interest in Blue Bottle Coffee
14/09/2017
This press release is also available in Français (pdf) and Deutsch (pdf) ....................................... Vevey, 14 September 2017 Nestlé acquires majority interest in Blue Bottle Coffee Nestlé today announced [...]
Increase of Nexstim Plc's share capital with subscriptions based on stock options 2013A
14/09/2017
Company announcement, Helsinki, 14 September 2017, at 7 PM Increase of Nexstim Plc's share capital with subscriptions based on stock options 2013A Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a [...]
La plateforme d'oncologie intégrée de CrownBio permet d'anticiper l'immunothérapie HERA GITRL prometteuse d'Apogenix pour le CPNPC et le cancer des voies aérodigestives supérieures
14/09/2017
SANTA CLARA, Californie, le 13 septembre 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services [...]
Medtronic Announces Inaugural 2017 Global Champions Team
14/09/2017
Athletes from Five Continents Benefitting from Medical Technology Will Showcase Remarkable Spirit at the Medtronic Twin Cities Marathon and Medtronic TC 10 Mile Events This October DUBLIN - September 14, 2017 - Long [...]
Targovax Receives 2017 Nordic Stars Award
14/09/2017
Oslo, Norway, 14 September 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that they are one [...]
Bavarian Nordic to Host Capital Markets Day in New York City
14/09/2017
COPENHAGEN, Denmark, September 14, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will host a capital markets day for institutional investors and equity analysts on Thursday, September 21, 2017 in New York City. At [...]
Summit Announces Underwritten Public Offering of 1,459,000 ADSs to Raise USD17.5 Million Before Expenses
14/09/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]
Terveystalo is planning an initial public offering and a listing on Nasdaq Helsinki Ltd
14/09/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA [...]
Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study
14/09/2017
51-week clinical study confirms that Sandoz proposed biosimilar adalimumab matches reference medicine Humira ® * safety and efficacy profile[1] Sandoz proposed biosimilar adalimumab is currently under review by the [...]
ABLYNX ANNOUNCES WARRANT EXERCISE
14/09/2017
REGULATED INFORMATION GHENT, Belgium, 14 September 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that [...]
Bone Therapeutics SA : Reports strong interim results from ALLOB® Phase IIA spinal fusion study
14/09/2017
Regulated information Bone Therapeutics reports strong interim results from ALLOB ® Phase IIA spinal fusion study Significant clinical and radiological improvements compared to baseline Results pave the way for future [...]
Bone Therapeutics SA : Annonce des résultats intermédiaires robustes dans l'étude de phase IIA avec ALLOB® dans la fusion vertébrale
14/09/2017
Information réglementée Bone Therapeutics annonce des résultats intermédiaires robustes dans l'étude de phase IIA avec ALLOB ® dans la fusion vertébrale Améliorations cliniques et radiologiques significatives par [...]
New Five-Year Gender Subset Data from the Medtronic Engage Registry Presented in VIVA Late Breaking Trials
13/09/2017
Five-Year, Real-World Data Demonstrate EVAR Outcomes with Endurant® II Stent Graft System Are Comparable in Both Male and Female Patients DUBLIN and LAS VEGAS - September 13, 2017 - Medtronic plc (NYSE: MDT) today [...]
CROSSJECT : Mise en oeuvre d'un contrat de liquidité
13/09/2017
Mise en oeuvre d'un contrat de liquidité avec Kepler Dijon, le 13 septembre 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de médicaments combinés innovants [...]
CROSSJECT : Bilan de fin de contrat de liquidité
13/09/2017
Bilan de fin de contrat de liquidité conclu avec CM-CIC Market Solutions Dijon, le 13 septembre 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de médicaments [...]
CROSSJECT : Descriptif du programme de rachat d'actions
13/09/2017
Descriptif du programme de rachat d'actions 2017-2018 Dijon, le 13 septembre 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de médicaments combinés innovants [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
13/09/2017
Information relative au nombre total de droits de vote et d'actions composant le capital social 13 septembre 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

Pages